The Franco-American startup Nabla has just crossed a strategic course with a lifting of $ 70 million (around 65 million euros) in series C. This funding, led by HV Capital with the participation of Highland Europe, DST Global, Cathay Innovation and the Collective Build of Tony Fadell, marks an acceleration towards an artificial intelligence truly integrated into care systems.
Nabla is no longer limited to lightening the documentary task of caregivers. The company now aims to establish a Agency software infrastructurecapable of understanding clinical contexts, executing orders in EHR (electronic medical files), code in real time, and to support medical decisions. Its assistant, already used by 85,000 clinicians and more than 130 establishments in the United States, covers new use cases: intensive care, nursing environments, pediatrics, mental health, and soon hospital establishments in rural areas.
“We are going even further in clinical workflows while continuing to offer a highly customizable assistant that works in all specialties,” says Alex Lebrun, co -founder and CEO. “Clinicians already trust our precision and our speed. This funding allows us to amplify this impact by integrating intelligent support directly into the care provision. We are considering a future where AI is not content to document care, but acts in favor of their effectiveness, by performing actions in complex environments. »»
The ambition is to make Nabla a Adaptive agent platformcapable of continuously treating more than 30 billion tokens per month, based on an LLM proprietary, specifically trained on clinical data. The company announces three major developments:
- A Coding proactive agentwith reinforced functions for the ICD-10, HCC and MCC, and real-time alerts on the conformity of consultation codes.
- A contextualcapable of using historical data to generate clinical summaries, pre-regain the files and execute orders in the EHR.
- A Paramedical care agentdesigned for nurses and leading staff, being deployed in general hospitals.
In a sector in full structuring, Nabla faces several direct competitors. Nuance (bought by Microsoft for nearly $ 20 billion) today dominates large hospital accounts with its Dragon Ambient Experience solution, but remains focused on Microsoft transcription and integration. Abridge, supported by Spark Capital, emphasizes the structured restitution in the EHR but does not yet offer agency capacities. Suki Ai, also well established in general practitioners, favors the voice interface and the simplicity of use. All share a generative technological base, but Nabla is distinguished by focusing on a proactive approach: execution of actions,, Advanced clinical customization,, multilingualismAnd Extended interoperability (Epic, Cerne, Athena, Nextgen…).
The efficiency documented by hospital partners is significant, according to studies conducted by University of Iowa Health Care and Denver Health, Nabla makes it possible to half the documentation time, while contributing to an improvement of 15 points of patient satisfaction. These results are accompanied by rapid growth, Nabla has multiplied by five its turnover in six months.
Alexander Joel-Carbonell, partner at HV Capital, underlines: “What Alex, Delphine and Martin built is simply remarkable. I have rarely seen technology deploy so quickly, arouse so much confidence, and offer such precision. More than 130 leading institutions are based today on Nabla. This is proof of their ability to combine technological excellence and empathy towards clinicians. »»
This dynamic is also based on a Agile deployment model. Nabla offers fluid integration with large EHRs on the market (Epic, Cerne, Athenahealth, etc.) and adopts a “Privacy-St” model, a guarantee of compliance in a sensitive regulatory environment. The company is also distinguished by its involvement in the governance of AI in health, via its commitment within the coalition for Health AI.
Dr. James Blum, Chief Health Information Officer at the University of Iowa, testifies: “We have never seen a technology adopted in this way in our organization. The deployment was rapid, the clinicians immediately took it in hand, and what strikes as much as technology is the relationship. Nabla listens, adapts and builds with us. This type of partnership really changes things. »»
Nabla was founded by Alex Lebrun (CEO), Delphine Groll (COO) and Martin Raison (CTO). His team also includes Dr. Ed Lee (Chief Medical Officer, former CIO of The Permanent Federation) and benefits from the support of experts like Yann Lecun (META) and Tony Fadell (Build Collective). With this lifting of $ 70 million (around 65 million euros), the company brings its total funding to $ 120 million. Nabla is based in New York and has among its CVS Health customers, Children’s Hospital Los Angeles, Carle Health, Denver Health and University of Iowa Health Care.
